Skip to main content

Table 2 Results per initiated cycles

From: Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea?

 

FHA PCOM (n = 104)

FHA (n = 85)

p

Ovulatory cycle rate

80.8 % (n = 84)

77.7 % (n = 66)

NS

Cancelled cycles rate

19.2 % (n = 20)

22.4 % (n = 19)

NS

- for excessive response

12.5 % (n = 13)

10.6 % (n = 9)

NS

- for poor response

1.9 % (n = 2)

0 % (n = 0)

NS

- for ovarian cyst

0 % (n = 0)

5.9 % (n = 5)

NA

- other

4.8 % (n = 5)

5.9 % (n = 5)

NS

Positive pregnancy test rate

32.7 % (n = 34)

24.7 % (n = 21)

NS

Clinical pregnancy rate

28.8 % (n = 31)

23.5 % (n = 20)

NS

Clinical ongoing pregnancy rate

26.9 % (n = 28)

20.0 % (n = 17)

NS

Miscarriage rate

2.9 % (n = 3)

3.5 % (n = 3)

NS

Multiple pregnancy rate

1.0  % (n = 1)

2.4 % (n = 2)

NS

Biochemical pregnancy rate

2.9 % (n = 3)

1.2 % (n = 1)

NS

Mean (+/− S.D) starting doses of GnRH chosen for the first cycle (μg):

   

- intravenous

4.9 (+/− 0.3)

5.3 (+/− 1.3)

NS

- subcutaneous

12.0 (+/− 4.6)

15.0 (+/− 4.5)

NS

Mean (+/− S.D) starting doses of GnRH (all cycles) (μg):

   

- intravenous

5.7 (+/− 2.1)

5.5 (+/− 2.1)

NS

- subcutaneous

11.8 (+/− 4.9)

13.1 (+/− 6.3)

NS